Advertisement

Topics

Biolipox AB (publ.) Company Profile

07:39 EDT 22nd June 2018 | BioPortfolio

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, chronic obstructive pulmonary disease (COPD), rhinitis, pain and arthritis. The discoveries that form the basis of our understanding of the role of arachidonic acid in inflammatory processes were rewarded with the Nobel Prize in 1982. One of the prize winners, Professor Bengt Samuelsson, is currently a member of the Board of Biolipox.

Arachidonic acid is an endogenous substance that through transformation to prostaglandins and leukotrienes regulates a number of inflammatory processes in the body. Biolipox's discovery of a new family - eoxins - formed from the transformation of arachidonic acid, marked the beginning of the company's research on an entirely new class of anti-inflammatory drugs

Location

Berzelius väg 3, plan 5
Solna
Sweden

Contact

Phone: 46 8-524 83 100
Fax: 46 8 524 83 101
Email: info@biolipox.com


News Articles [60 Associated News Articles listed on BioPortfolio]

Aino Health AB (publ): Publication of annual report postponed

    April 6, 2018 Aino Health AB (publ) postpones the publication of the annual report for 2017 until May 9, 2018.The primely release date was April 10, 2018. The reason for th...

Annual Report of Volvo Treasury AB (publ)

Annual Report of Volvo Treasury AB (publ) Read more...

Nasdaq Stockholm AB: Delisting from Nasdaq Stockholm of Wilson Therapeutics AB (publ) (97/18)

Wilson Therapeutics AB (publ) has requested a delisting of the company's shares from Nasdaq Stockholm. Nasdaq Stockholm AB has approved the application and decided to delist the shares of Wilson Th...

Oasmia Pharmaceutical AB (publ)

Interim report for the period May 2017 – January 2018 Commercial focus and lower cost base THIRD QUARTER November 1, 2017 – January 31, 2018 Consolid...

Annual Report 2017 Active Biotech AB (publ)

    PRESS RELEASE Active Biotech's Annual Report 2017 is now available för download at www.activebiotech.com. The Annual Report will only be digitally distributed. The Engl...

MPI - Resolution to implement merger

Hoersholm, Denmark, May 30, 2018 - today, an extraordinary general meeting Medical Prognosis Institute A/S was held. A summary of the resolutions adopted follows below. All resolutions ...

Change in Number of Shares and Voting Rights in Invuo Technologies AB (publ)

Change in Number of Shares and Voting Rights in Invuo Technologies AB (publ) Read more...

Bulletin from the Annual Shareholders’ Meeting on May 24, 2018 in Saniona AB (Publ)

PRESS RELEASE May 24, 2018 Today, on May 24, 2018, an annual shareholders’ meeting was held in Saniona AB (publ). A summary of the resolutions adopted follows below. All resolutions were adopted...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Kepivance [Swedish Orphan Biovitrum AB (publ)]

These highlights do not include all the information needed to use Kepivance safely and effectively. See full prescribing information for Kepivance.Kepivance® (palifermin) For injection, for intraveno...

Kineret [Swedish Orphan Biovitrum AB (publ)]

These highlights do not include all the information needed to use Kineret safely and effectively. See full prescribing information for Kineret. Kineret® (anakinra) For injection, for subcutaneous use...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [16 Associated Companies listed on BioPortfolio]

Biolipox AB (publ.)

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, c...

Biolipox AB

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, c...

Swedish Orphan Biovitrum AB (publ)

Karolinska Development AB (publ), and BioChromix AB

Karolinska Development manages one of the largest portfolios of life science companies in Europe.

Vitrolife AB (publ)

The fourth of the total of twelve patients included in the USA study for STEEN Solution™, and which enables sales approval in the important USA market, has now received a tra...

More Information about "Biolipox AB (publ.)" on BioPortfolio

We have published hundreds of Biolipox AB (publ.) news stories on BioPortfolio along with dozens of Biolipox AB (publ.) Clinical Trials and PubMed Articles about Biolipox AB (publ.) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biolipox AB (publ.) Companies in our database. You can also find out about relevant Biolipox AB (publ.) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Corporate Database Quicklinks



Searches Linking to this Company Record